Parathyroid hormone-related protein, human adipose-derived stem cells adipogenic capacity and healthy obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 6, 2015, Pages E826-E835

  Roca Rodríguez, María Mar ^a   Bekay, Rajaa El ^a   Garrido Sanchez, Lourdes ^a   Gómez Serrano, María ^b   Coin Aragüez, Leticia ^a   Oliva Olivera, Wilfredo ^a   Lhamyani, Said ^a   Clemente Postigo, Mercedes ^a   García Santos, Eva ^b   De Diaz, Resi Luna ^c   Yubero Serrano, Elena M ^d   Real, José M Fernández ^e   Peral, Belén ^b   Tinahones, Francisco J ^a  

^a Unidad de Gestión Clínica Endocrinología y Nutrición   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE SILENCING; HIP CIRCUMFERENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MALE; MESENCHYMAL STEM CELL; MORBID OBESITY; MOUSE; NONHUMAN; NUCLEOLUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PTHRP GENE; STROMA CELL; SUBCUTANEOUS FAT; 3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL; BLOOD; BODY WEIGHT; CELL CULTURE; HEALTH; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; OBESITY; OBESITY, MORBID; PARATHYROID HORMONE-RELATED PROTEIN; THINNESS;

EID: 84930811235     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4132     Document Type: Article

References (42)

1. World Health Organization. Fact Sheet No. 311; WHO, Geneva, Switzerland; 2006
2. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119:S10-S16.
3. Scherer PE. Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes. 2006;55:1537-1545.
4. Tan CY, Vidal-Puig A. Adipose tissue expandability: The metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans. 2008;36:935-940.
5. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453:783-787.
6. Lagathu C, Christodoulides C, Tan CY, et al. Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int J Obes. 2010;34:1695-1705.
7. -Reeve J.PTH: A future role in the management of osteoporosis? J Bone Miner Res. 1996;11:440-445.
8. Kano J, Sugimoto T, Fukase M, Chihara K. Direct involvement of cAMP-dependent protein kinase in the regulation of alkaline phosphatase activity by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic UMR-106 cells. Biochem Biophys Res Commun. 1994;199:271-276.
9. Kronenberg HM, Lee K, Lanske B, Segre GV. Parathyroid hormonerelated protein and Indian hedgehog control the pace of cartilage differentiation. J Endocrinol. 1997;154(Suppl):S39-S45.
10. Tang QQ, Lane MD. Adipogenesis: From stem cell to adipocyte. Annu Rev Biochem. 2008;81:715-736.
11. Guise TA, Yin JJ, Thomas RJ, Dallas M, Cui Y, Gillespie MT. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone. 2002;30:670-676.
12. Tobias JH, Cooper C. PTH/PTHrP activity and the programming of skeletal development in utero. J Bone Miner Res. 2004;19:177-182.
13. Ogino K, Ogura K, Kinugasa Y, Furuse Y, Uchida K, Shimoyama M, Kinugawa T, Osaki S, Kato M, Tomikura Y, Igawa O, Hisatome I, Bilezikian JP, Shigemasa C. Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure. J Clin Endocrinol Metab. 2002;87:4722-4727.
14. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999;104: 439-446.
15. Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karaplis AC. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology. 2001;142:4900-4909.
16. Legakis I. The role of parathyroid hormone-related protein (PTHrP) in the pathophysiology of diabetes mellitus. Mini Rev Med Chem. 2009;9(6):717-23.
17. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilinage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7: 211-226.
18. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: A mechanism for regulation of adipogenesis by hypoxia. Dev Cell. 2002;2:331-341.
19. Janderová L, McNeil M, Murrell AN, Mynatt RL, Smith SR. Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res. 2003;11(1):65-74.
20. Ochs RL, Lischwe MA, Spohn WH, Busch H. Fibrillarin: A new protein of the nucleolus identified by autoimmune sera. Biol Cell. 1985;54:123-133.
21. Carpio L, Gladu J, Goltzman D, Rabbani SA. Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways. Am J Physiol. 2001;281:E489-E499.
22. Petersen RK, Jørgensen C, Rustan AC, et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res. 2003;44(12):2320-2330.
23. Chan GK, Miao D, Deckelbaum R, Bolivar I, Karaplis A, Goltzman D. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells. Endocrinology. 2003;144(12):5511-20.
24. Miao D, Tong XK, Chan GK, Panda D, McPherson PS, Goltzman D. Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem. 2001; 276:32204-32213.
25. Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem. 2002;277(48):46226-46232.
26. Nikolopoulou E, Papacleovoulou G, Jean-Alphonse F, et al. Arachidonic acid-dependent gene regulation during preadipocyte differentiation controls adipocyte potential. J Lipid Res. 2014;55(12): 2479-2490.
27. Kronenberg HM. Developmental regulation of the growth plate. Nature. 423(6937):332-336.
28. Kronenberg HM. PTHrP and skeletal development. Ann N Y Acad Sci. 2006;1068:1-13.
29. Hirata M, Kugimiya F, Fukai A, et al. C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS One. 2009;4(2):e4543.
30. Qin L, Qiu P, Wang L, et al. Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem. 2003 May;278(22):19723-3130.
31. Lefterova MI, Zhang Y, Steger DJ, et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008;22(21):2941-2952.
32. White UA, Stephens JM. Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol. 2010;318:10-14.
33. Casado-Diaz A, Santiago-Mora R, Quesada JM. The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells. Exp Mol Med. 2010;42(2):87-98.
34. Chung SS, Lee JS, Kim M, et al. Regulation of Wnt/β-catenin signaling by CCAAT/enhancer binding protein β during adipogenesis. Obesity (Silver Spring). 2012;20:482-487.
35. Dunbar ME, Wysolmerski JJ. Parathyroid hormone-related protein: A developmental regulatory molecule necessary for mammary gland development. J. Mammary Gland Biol Neoplasia. 1999;4: 21-34.
36. Hiremath M, Dann P, Fischer J, et al. Parathyroid hormone-related protein activates Wnt signaling to specify the embryonic mammary mesenchyme. Development. 2012;139:4239-4249.
37. Foley J, Dann P, Hong J, et al. Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development. 2001;128:513-525.
38. Foster MT, Pagliassotti MJ. Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location. Adipocyte. 2012;1:192-199.
39. Roldan M, Macias-Gonzalez M, Garcia R, Tinahones FJ, Martin M. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J. 2011;25:4111-4126.
40. Henderson JE, Amizuka N, Warshawsky H, et al. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol. 1995;15:4064-4075.
41. Henderson JE, He B, Goltzman D, Karaplis AC. Constitutive expression of parathyroid hormone-related peptide (PTHrP) stimulates growth and inhibits differentiation of CFK2 chondrocytes. J Cell Physiol. 1996;169:33-41.
42. Aarts MM, Rix A, Guo J, Bringhurst R, Henderson JE. The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation. J Bone Miner Res. 1999;14:1493-1503.